Literature DB >> 8353424

Biochemical genetics: examples of life after cloning.

R R McInnes1, P H Byers.   

Abstract

The blend of biochemistry and molecular biology required to understand the pathogenesis of genetic disease is assuming an increasing role in research. We review three example of this inevitable post-cloning trend: first, the surprising relationship between mice with albino deletions and human hereditary tyrosinemia type I; second, the discovery that choroideremia is due to defect in prenylation; and third, fibrillin mutations in the Marfan syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8353424     DOI: 10.1016/0959-437x(93)90123-7

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  4 in total

1.  Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene.

Authors:  G Collod-Béroud; C Béroud; L Adès; C Black; M Boxer; D J Brock; M Godfrey; C Hayward; L Karttunen; D Milewicz; L Peltonen; R I Richards; M Wang; C Junien; C Boileau
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

2.  Marfan Database (third edition): new mutations and new routines for the software.

Authors:  G Collod-Béroud; C Béroud; L Ades; C Black; M Boxer; D J Brock; K J Holman; A de Paepe; U Francke; U Grau; C Hayward; H G Klein; W Liu; L Nuytinck; L Peltonen; A B Alvarez Perez; T Rantamäki; C Junien; C Boileau
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

3.  Software and database for the analysis of mutations in the human FBN1 gene.

Authors:  G Collod; C Béroud; T Soussi; C Junien; C Boileau
Journal:  Nucleic Acids Res       Date:  1996-01-01       Impact factor: 16.971

4.  Differential allelic expression of a fibrillin gene (FBN1) in patients with Marfan syndrome.

Authors:  D Hewett; J Lynch; A Child; H Firth; B Sykes
Journal:  Am J Hum Genet       Date:  1994-09       Impact factor: 11.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.